DBS Therapy Effects for Parkinson's Disease
Udall Project 2 Aim 2A&C
Recruiting
Observational Study
Parkinson Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 36 (estimated)
- Sponsor
- University of Minnesota · Other
Who this trial is looking for
This trial is looking for people with Parkinson's disease who are receiving DBS therapy. Participants will help researchers understand how DBS affects motor behavior and movement over at least 4 weeks.
Are You a Good Fit for This Trial?
You may be able to join if
- I have Parkinson's disease.
- I am receiving DBS therapy in the globus pallidus.
- I have a Medtronic Percept DBS system implanted.
- At least 3 months have passed since my neurostimulator was activated.
- I have DBS settings that are compatible for sensing.
You may not be able to join if
- I have a history of musculoskeletal disorders that affect my motor tasks.
- I have a history of dementia or cognitive impairment.
- I have another significant neurological disorder.
- I have post-operative complications that affect my safety.
- I cannot give informed consent.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This protocol will leverage the novel (on-label, FDA-approved) local field potential measuring capability of the Medtronic Percept™ PC or RC DBS system to study the effects of globus pallidus internus, globus pallidus externus (GPi, GPe), and subthalamic nucleus (STN) DBS on: the wash-out and wash-in dynamics of motor behavior and local field potentials (LFPs) and correlations between fluctuations…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Receiving DBS therapy in GP for treatment of PD
* Implanted with Medtronic Percept DBS system
* At least 3 months since initial activation of the neurostimulator
* For the "At Home" experiment only: participants with DBS settings that are sensing compatible.
Exclusion Criteri…
Contacts